Correlation Between Elevation Oncology and Rain Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Elevation Oncology and Rain Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elevation Oncology and Rain Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elevation Oncology and Rain Therapeutics, you can compare the effects of market volatilities on Elevation Oncology and Rain Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elevation Oncology with a short position of Rain Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elevation Oncology and Rain Therapeutics.

Diversification Opportunities for Elevation Oncology and Rain Therapeutics

0.49
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Elevation and Rain is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Elevation Oncology and Rain Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rain Therapeutics and Elevation Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elevation Oncology are associated (or correlated) with Rain Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rain Therapeutics has no effect on the direction of Elevation Oncology i.e., Elevation Oncology and Rain Therapeutics go up and down completely randomly.

Pair Corralation between Elevation Oncology and Rain Therapeutics

If you would invest  60.00  in Elevation Oncology on August 27, 2024 and sell it today you would earn a total of  0.00  from holding Elevation Oncology or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy4.76%
ValuesDaily Returns

Elevation Oncology  vs.  Rain Therapeutics

 Performance 
       Timeline  
Elevation Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Elevation Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
Rain Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Rain Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward indicators, Rain Therapeutics is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Elevation Oncology and Rain Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Elevation Oncology and Rain Therapeutics

The main advantage of trading using opposite Elevation Oncology and Rain Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elevation Oncology position performs unexpectedly, Rain Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rain Therapeutics will offset losses from the drop in Rain Therapeutics' long position.
The idea behind Elevation Oncology and Rain Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Global Correlations
Find global opportunities by holding instruments from different markets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA